Fair Value Calculator Fair Value Calculator
EN DE

CLIOINFO (CLIOINFO) Fair Value & Analysis

IN · Market cap ₹106M

C CLIOINFO CLIOINFO · BSE
Price₹9.63
Fair Value₹10.23
Upside+6.2%
Quality70/100
Watch CLIOINFO for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹10.23 – ₹12.78

Fair value as of: Jul 5, 2026

From 23 valuation models · updated today

Share price +7.0% over the past month.

Price vs Fair Value (12 months)

₹10.10 ₹4.15 Fair Value ₹10.23 Jul 2025 Jul 2026

12‑month range ₹4.15 – ₹10.10 · fair‑value band ₹10.23 – ₹12.78 · the ₹9.63 price screens below the ₹10.23 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

CLIOINFO (CLIOINFO) currently trades at ₹9.63, while our model-based Fair Value estimate is ₹10.23 — implying the stock looks roughly 6.2% undervalued today. We read business quality at 70/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, CLIOINFO generated revenue of ₹30.1M at a net margin of 22.0%. It earns a return on equity of 4.9%. Net debt stands at ₹111M. The stock trades on a trailing P/E of 16.1. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹10.23 (bear case) to ₹12.78 (bull case); at ₹9.63, the current price sits below that range. The share trades about 9% below its 52-week high and 137% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹30.1M
Revenue growth (YoY) +594%
Net margin 22.0%
Return on equity 4.9%
Free cash flow ₹24.7M FY2026
P/E ratio 16.1
More key figures
Operating margin 43.5%
EPS (TTM) ₹0.6000
EPS growth (YoY) +1,150%
Net debt ₹111M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

CLIOINFO reported revenue of ₹28.4M in FY2026 versus ₹0 in FY2022. Reported net income was ₹6.6M in FY2026.

Revenue
FY22 ₹0
FY23 ₹184K
FY24 ₹1.5M
FY25 ₹1.5M
FY26 ₹28.4M
Net income
FY22 −₹5.5M
FY23 −₹3.0M
FY24 ₹199K
FY25 ₹571K
FY26 ₹6.6M

Is CLIOINFO fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "CLIOINFO Fair Value". https://www.fairvalue-calculator.com/stock/CLIOINFO

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is CLIOINFO (CLIOINFO) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹10.23 versus a price of ₹9.63 — about +6% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CLIOINFO?
Our model-based fair value for CLIOINFO is ₹10.23 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹9.63.
What is the quality score of CLIOINFO?
CLIOINFO has a Quality Score of 70/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of CLIOINFO (CLIOINFO)?
CLIOINFO reported trailing-twelve-month revenue of about ₹30.1M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CLIOINFO?
The net profit margin of CLIOINFO is about 22.0%, meaning it keeps roughly 22.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.